Apnimed
PrivateLast Round
Debt
Mar 27, 2026
Total Funding Raised
$227.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Apnimed is a pharmaceutical company that develops novel oral therapies for the treatment of obstructive sleep apnea and other sleep-related breathing diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apnimed Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Apnimed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 27, 2026 | ||||
| Early Funding | Oct 7, 2025 | ||||
| IPO Announced | Jun 6, 2025 | ||||
| Series C Extension | Jan 3, 2023 | ||||
| Series C | May 4, 2022 | ||||
Series B | Mar 25, 2021 |
Key People
Founding team and executive leadership
Apnimed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ameriprise | Series B |
| HealthCare Royalty Partners | Debt |
| Columbia Threadneedle Investments | Series C Extension |
| Morningside Ventures | Series C, Series A, Series B |
| J. & W. Seligman & Company | Series C, Series B |
| Sectoral | Series C, Series C Extension |
| Morningside Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Job posting indicates AD109 is preparing for launch.
- Mar 27, 2026
$25M debt round raised.
Apnimed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apnimed's valuation, stock price, and market status.